Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit

Featuring perspectives from Dr Edward B Garon and Dr Corey J Langer, including the following topics.

Role of Immune Checkpoint Inhibitors in Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) — Dr Langer (0:00)

Immune Checkpoint Inhibitors and Other Emerging Therapeutic Approaches for Metastatic NSCLC without a Targetable Tumor Mutation — Dr Garon (30:08)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.